You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Novel Therapeutic Approaches for Chronic Rhinosinusitis With Nasal Polyps: From Clinical Trials to Guideline Recommendations

  • Authors: Raj Sindwani, MD; Claus Bachert, MD, PhD; Leigh Sowerby, MD, MHM, FRCSC; Shigeharu Fujieda, MD, PhD
  • CME Released: 3/8/2022
  • Valid for credit through: 3/8/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for allergists and clinical immunologists, surgeons (including ear, nose, and throat specialists [ENTs]), nurse practitioners (NPs; allergy/clinical immunology and ENT), physician assistants (PAs; allergy/clinical immunology and ENT).

The goal of this activity is that learners will be better able to manage and treat patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Pathophysiology of CRSwNP and its relationship to comorbid diseases
    • Clinical trial data on biologics in CRSwNP
    • Recent guideline updates for the management of CRSwNP


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Raj Sindwani, MD

    Professor of Otolaryngology
    Vice Chairman and Section Head of Rhinology
    Head & Neck Institute of the Cleveland Clinic
    Cleveland, Ohio

    Disclosures

    Consultant or advisor for: Acclarent, Inc.; Optinose, Inc.; Stryker, Inc.

  • Claus Bachert, MD, PhD

    Professor
    Chief of Clinics
    Upper Airways Research Laboratory
    ENT Department
    Ghent University
    Ghent, Belgium
    Professor
    Division of ENT Diseases
    CLINTEC, Karolinska Institutet
    Stockholm, Sweden
    First Affiliated Hospital
    Sun Yat-Sen University
    Guangzhou, China

    Disclosures

    No relevant financial relationships

  • Leigh Sowerby, MD, MHM, FRCSC

    Associate Professor
    Rhinology and Anterior Skull Base Surgery
    Otolaryngology - Head and Neck Surgery
    Western University
    Ontario, Canada

    Disclosures

    Consultant or advisor for: Darvis; Freudenberg Medical; Olympus
    Speaker or member of speakers bureau for: GlaxoSmithKline; Mylan; Sanofi
    Research funding from: AstraZeneca; GlaxoSmithKline; Optinose

  • Shigeharu Fujieda, MD, PhD

    Chairman and Professor
    Department of Otorhinolaryngology
    Head & Neck Surgery
    University of Fukui
    Fukui, Japan

    Disclosures

    No relevant financial relationships

Editor

  • Karen Badal, MD, MPH

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Karen Badal, MD, MPH, has disclosed no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC  

    Disclosures

    Amanda Jett, PharmD, BCACP has disclosed no relevant financial relationships.  

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Novel Therapeutic Approaches for Chronic Rhinosinusitis With Nasal Polyps: From Clinical Trials to Guideline Recommendations

Authors: Raj Sindwani, MD; Claus Bachert, MD, PhD; Leigh Sowerby, MD, MHM, FRCSC; Shigeharu Fujieda, MD, PhDFaculty and Disclosures

CME Released: 3/8/2022

Valid for credit through: 3/8/2023

processing....

Educational Impact Challenge

The goal of this activity is that learners will be better able to manage and treat patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print